Literature DB >> 12507555

Deregulated degradation of the cdk inhibitor p27 and malignant transformation.

Joanna Bloom1, Michele Pagano.   

Abstract

p27 acts as a critical negative regulator of the cell cycle by inhibiting the activity of cyclin/cdk complexes during G0 and G1. Degradation of p27 is a critical event for the G1/S transition and occurs through ubiquitination by SCF(Skp2) and subsequent degradation by the 26S-proteasome. A tumor suppressing function of p27 has been demonstrated in mouse models and studies of human tumors. More recent evidence suggests that Skp2, the specific recognition factor for p27 ubiquitination, has oncogenic properties. This review will focus on the regulation of p27 proteolysis and its consequences for tumorigenesis. Copyright 2002 Elsevier Science Ltd.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12507555     DOI: 10.1016/s1044-579x(02)00098-6

Source DB:  PubMed          Journal:  Semin Cancer Biol        ISSN: 1044-579X            Impact factor:   15.707


  110 in total

1.  Expression of cell cycle regulators p21 and p27 as predictors of disease outcome in colorectal carcinoma.

Authors:  Jaudah Al-Maghrabi; Mahmoud Al-Ahwal; Abdelbaset Buhmeida; Kari Syrjänen; Abdulrahman Sibyani; Eman Emam; Ayman Ghanim; Mohmmad Al-Qahtani
Journal:  J Gastrointest Cancer       Date:  2012-06

Review 2.  The role of deubiquitinating enzymes in apoptosis.

Authors:  Suresh Ramakrishna; Bharathi Suresh; Kwang-Hyun Baek
Journal:  Cell Mol Life Sci       Date:  2010-08-21       Impact factor: 9.261

3.  Skp2 targeting suppresses tumorigenesis by Arf-p53-independent cellular senescence.

Authors:  Hui-Kuan Lin; Zhenbang Chen; Guocan Wang; Caterina Nardella; Szu-Wei Lee; Chia-Hsin Chan; Chan-Hsin Chan; Wei-Lei Yang; Jing Wang; Ainara Egia; Keiichi I Nakayama; Carlos Cordon-Cardo; Julie Teruya-Feldstein; Pier Paolo Pandolfi
Journal:  Nature       Date:  2010-03-18       Impact factor: 49.962

4.  Foxo3a transcription factor is a negative regulator of Skp2 and Skp2 SCF complex.

Authors:  J Wu; S-W Lee; X Zhang; F Han; S-Y Kwan; X Yuan; W-L Yang; Y S Jeong; A H Rezaeian; Y Gao; Y-X Zeng; H-K Lin
Journal:  Oncogene       Date:  2012-02-06       Impact factor: 9.867

5.  Possible implication of Mdm2 as a prognostic marker in invasive laryngeal carcinoma.

Authors:  Marcela K Hassumi-Fukasawa; Fabiana A Miranda-Camargo; Márcia C M Guimarães; Renata T Simões; Eduardo A Donadi; Christiane P Soares; Edson G Soares
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-02-05       Impact factor: 2.503

6.  Phosphorylation of p27Kip1 by Epstein-Barr virus protein kinase induces its degradation through SCFSkp2 ubiquitin ligase actions during viral lytic replication.

Authors:  Satoko Iwahori; Takayuki Murata; Ayumi Kudoh; Yoshitaka Sato; Sanae Nakayama; Hiroki Isomura; Teru Kanda; Tatsuya Tsurumi
Journal:  J Biol Chem       Date:  2009-05-18       Impact factor: 5.157

7.  Partial molecular characterization, expression pattern, polymorphism and association analysis of porcine SKP2 gene.

Authors:  Y Li; S L Yang; Z L Tang; W T Cui; Y L Mu; M X Chu; S H Zhao; Z F Wu; K M Peng; K Li
Journal:  Mol Biol Rep       Date:  2009-03-26       Impact factor: 2.316

8.  Role of Cks1 overexpression in oral squamous cell carcinomas: cooperation with Skp2 in promoting p27 degradation.

Authors:  Shojiro Kitajima; Yasusei Kudo; Ikuko Ogawa; Tarig Bashir; Masae Kitagawa; Mutsumi Miyauchi; Michele Pagano; Takashi Takata
Journal:  Am J Pathol       Date:  2004-12       Impact factor: 4.307

9.  Brain tumor senescence might be mediated by downregulation of S-phase kinase-associated protein 2 via butylidenephthalide leading to decreased cell viability.

Authors:  Mao-Hsuan Huang; Shinn-Zong Lin; Po-Cheng Lin; Tzyy-Wen Chiou; Yeu-Wei Harn; Li-Ing Ho; Tzu-Min Chan; Chih-Wei Chou; Chang-Han Chuang; Hong-Lin Su; Horng-Jyh Harn
Journal:  Tumour Biol       Date:  2014-01-26

10.  p27Kip1 modulates cell migration through the regulation of RhoA activation.

Authors:  Arnaud Besson; Mark Gurian-West; Anja Schmidt; Alan Hall; James M Roberts
Journal:  Genes Dev       Date:  2004-04-12       Impact factor: 11.361

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.